Promotional · LEO PharmaUK HCPs only

Catch the bubble

Almost

Calcipotriol monohydrate & betamethasone dipropionate.

Enstilar® foam vs Dovobet® ointment.

More than one in two were clear or almost clear at Week 4.*

Head to head against Dovobet® ointment.2,3 P=0.025

54.6%

43.0%

Enstilar® foam
n=77/141

Dovobet® ointment
n=58/135

*Recommended treatment durations are 4 weeks (non-scalp).1,4 Adapted from Koo J, et al. 2016.2

(calcipotriol/betamethasone dipropionate) cutaneous foam

See the Week 4 data

For UK healthcare professionals only. Click here for Prescribing information and adverse event reporting. Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to LEO Pharma on +44 (0)1844 347333. MAT-XXXXX · concept, not approved.

For UK healthcare professionals only.Prescribing information & adverse event reporting